The need for standardisation of the HIV continuum of care

In July, 2014, the Joint UN Programme on HIV/AIDS (UNAIDS) proposed an ambitious new target calling for 90% of HIV-infected individuals to be diagnosed, 90% of them to be on combination antiretroviral therapy (ART), and 90% of them to achieve sustained virological suppression, worldwide.1 Achieving this 90-90-90 target by 2020 would, by 2030, decrease the burden of HIV/AIDS by 90% from that in 2010. However, to meet these targets standardised and continuous global monitoring of HIV care outputs should become a priority.

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025